The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant trastuzumab and vinorelbine (TV) for early-stage HER2+ breast cancer.
 
Shannon McLaughlin
No Relationships to Disclose
 
Erika Nakajima
No Relationships to Disclose
 
Steven J. Isakoff
Employment - Merus (I)
Consulting or Advisory Role - Novartis; Paxman; Puma Biotechnology; Seagen
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Genentech (Inst); Merck (Inst); OncoPep (Inst); Outcomes4Me (Inst)
 
Jennifer Shin
No Relationships to Disclose
 
Beverly Moy
Consulting or Advisory Role - MOTUS (I)
Research Funding - Puma Biotechnology (Inst)
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo/Astra Zeneca; Foundation Medicine; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Philips Healthcare; Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Irene Kuter
Stock and Other Ownership Interests - Rubius Therapeutics (I)
Honoraria - Alexion (Syntimmune), Agios, Alnylam, Amgen, Argenx, BioCryst, Bristol Myers Squibb (BMS), Caremark, CRICO, Daiichi Sankyo, Dova, Genzyme, Immunovant, Incyte, Kyowa-Kirin, Merck Sharp Dohme, Momenta, Novartis, Pfizer, Platelet Disorder Support Association (I)
Consulting or Advisory Role - Alexion (Syntimmune), Amgen, Argenx, BioCryst, Bristol Myers Squibb (BMS), Caremark, Cellularity, Cellphire, CRICO, Daiichi Sankyo, Hengrui. Immunovant, Incyte, Kyowa-Kirin, Merck Sharp Dohme, Momenta, Novartis, Pfizer, Platelet Biogenesis, Platelet Disor (I)
Research Funding - Argenx, Biocryst, Immunovant, Principia, Rigel, Takeda (Bioverativ), UCB (I)
Patents, Royalties, Other Intellectual Property - Up-to-Date chapters (I)
(OPTIONAL) Uncompensated Relationships - Platelet Disorders Support Association Medical Board Member (I)
 
Laura Spring
Consulting or Advisory Role - Avrobio; Novartis; Puma Biotechnology
Research Funding - Merck (Inst); Philips Healthcare (Inst)